US$ 21.40
how long have glp 1 drugs been around GLP-1s were first approved in 2005 for the treatment of type 2 diabetes. Over the past two decades, more versions of the medication hit the market, becoming more accessible to patients GLP-1 agents, the 20-year 'overnight
Description
Because obesity is a chronic disease, many patients end up discovering that GLP-1 treatment is not really a short-term intervention

Targeting mitochondrial quality control for diabetic cardiomyopathy: therapeutic potential of hypoglycemic drugs
Treatment of osteoarthritis with incretin hormones or analogues thereof

16 Matthias Tschp and his team discovered that dual agonists targeting both GLP-1 and GIP receptors (GIPR) are more effective in treating diabetes than those targeting only GLP-1R

The potential actions of GLP-1 medicines in modulating astrocyte-mediated neuroinflammation have not been extensively explored

Tirzepatide may make oral contraceptives less effective